Press Releases

Evestia Clinical - the new brand identity for EMAS Pharma - launches today

EMAS Pharma has officially rebranded as Evestia Clinical, signaling a bold new chapter as a specialised Contract Research Organization (CRO) dedicated to oncology and rare disease clinical trials. With the backing of Kester Capital and a leadership team with a proven track record, Evestia Clinical is set to redefine the clinical research landscape by delivering agile, expert-driven solutions to biotech innovators worldwide. With a rapidly growing demand for faster, more adaptive trials in complex therapeutic areas, this transformation comes at a critical time for the industry. The new identity underscores the company’s commitment to accelerating life-changing therapies to market while strengthening its strategic partnerships with biotech firms globally.

High Force Research Appoints Chief Commercial Officer to Drive Growth

High Force Research, a leading UK-based provider of specialist chemical R&D and manufacturing services has just appointed Dr. Nathalie Huther as its first-ever Chief Commercial Officer following a recent management buyout. This is a pivotal moment for the company, as it gears up to accelerate growth and deepen its presence in the pharmaceutical, biotech, and specialty chemicals markets. Nathalie brings 15+ years of commercial leadership experience across the chemical and life sciences sectors and will be steering High Force Research’s business development and market expansion strategy.

Phastar Secures Finalist Spot at 2025 Citeline Awards

Phastar, a global specialist biometrics & data science Contract Research Organization (CRO), has been shortlisted in the ‘CRO Partnership of the Year’ category at the 2025 Citeline Awards for its collaboration with Medicines Development for Global Health (MDGH), a not for profit pharmaceutical company dedicated to the development of affordable medicines for the people who need them most.

Cellistic Launches Echo™ – NK Platform, a Scalable Solution for Off-the-Shelf Allogeneic Immune Cell

News from Cellistic, which has launched its new Echo™-NK platform to support the production of off-the-shelf Natural Killer cell therapies. The platform offers a cost-effective, GMP-compliant solution for scaling iPSC-derived NK cells, aimed at treating cancers and autoimmune diseases. It also integrates Cellistic’s STAR-CRISPR and Pulse technologies to help speed up development, with several client projects already in progress.

Cepheid and Oxford Nanopore Technologies Partner to Advance Automated Sequencing-Based Solutions

Cepheid and Oxford Nanopore Technologies announce new collaboration to develop an integrated sequencing workflow to advance infectious disease analysis.

ELRIG Appoints Dr Del Trezise as Chair

Phenomix Sciences Announces First Prospective Clinical Study of Semaglutide Using MyPhenome™ Test

Building on a decade of research and validation, study leverages precision, phenotype-guided treatment for enhanced patient outcomes on GLP-1s.

CDMO Upperton Continues Growth with the Appointment of Michael Mellor-Clark as Chief Commercial Officer.

Upperton Pharma Solutions, a leading UK-based contract development and manufacturing organisation (CDMO), continues its growth following the build of a new sterile manufacturing facility with the appointment of Michael Mellor-Clark as Chief Commercial Officer (CCO).

Indivumed Celebrates Milestone of Its Patient-Centric R&D Platform: Numerous Novel Cancer Targets Discovered for First-in-Class Therapeutics

Indivumed is proud to announce major milestones achieved, cementing its position as a leading oncology R&D company.

George Clinical Rebrands as Emerald Clinical Trials

New name reflects company’s growth and vision to help bring certainty and transparency to global clinical trials

AES Cleanroom Technology introduces Omni ASCENT: a breakthrough in cleanroom utility integration at INTERPHEX 2025

ONTOFORCE’s DISQOVER Chosen by The Michael J. Fox Foundation to Enhance the Integration and Access of Parkinson’s Disease Research Data

ONTOFORCE has announced a collaboration with The Michael J. Fox Foundation for Parkinson’s Research (MJFF).

WCG Announces Research Resilience Solutions to Navigate Institutional Budget Constraints

WCG has announced the release of Research Resilience Solutions, a site optimization initiative and industry-wide thought leadership series aimed at supporting institutions facing significant funding constraints.

Veeva Announces Research Site Clinical Trial Management System

Cloud CTMS software to improve research site efficiency and integrate seamlessly with sponsors.

Kindeva Appoints Daniel J. Speciale as the New Chief Financial Officer (CFO)

CluePoints Appoints Usama Dar as Chief Product and Technology Officer

CluePoints, provider of leading statistical and AI-driven software solutions, has today announced Usama Dar as its new Chief Product and Technology Officer.

Genomize and Genomenon Partner to Empower Researchers and Clinicians with Comprehensive Genomic Insights

Genomenon and Genomize today announced a new partnership that brings together the best of genomic intelligence and next-generation sequencing technology to transform how genomic data is interpreted. Through this integration, Genomenon’s Mastermind® Genomic Intelligence Platform and Cancer Knowledgebase (CKB) are now seamlessly embedded within Genomize’s SEQ Platform, enabling a unified and deeply enriched analysis environment. This partnership marks a major step forward in streamlining genomic analysis and advancing precision medicine—especially across Europe, the Middle East, and Asia, where Genomize is actively leading innovation.

WCG ClinSphere™ Total Feasibility Releases Self-Serve Capabilities that Optimize Clinical Trial Site Selection

WCG announced today the launch of WCG ClinSphere™ Total Feasibility’s Software-as-a-Service (SaaS) technology solution, designed to address the most important clinical trial study start-up decisions for sponsors and contract research organizations (CROs).

Inizio Medical Launches iON.AI to Transform Medical Affairs Capabilities

Andaman7 Seeks $5m to Continue Investment in Pioneering Technology

Andaman7, the platform transforming healthcare communications and bridging the gap between patients and researchers, is seeking investment to reach the next milestones in its ground-breaking journey.